Excellus Health Plan, Inc. v. Tran

287 F. Supp. 2d 167, 2003 U.S. Dist. LEXIS 18480, 2003 WL 22382948
CourtDistrict Court, W.D. New York
DecidedAugust 29, 2003
Docket1:03-cr-00095
StatusPublished
Cited by15 cases

This text of 287 F. Supp. 2d 167 (Excellus Health Plan, Inc. v. Tran) is published on Counsel Stack Legal Research, covering District Court, W.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Excellus Health Plan, Inc. v. Tran, 287 F. Supp. 2d 167, 2003 U.S. Dist. LEXIS 18480, 2003 WL 22382948 (W.D.N.Y. 2003).

Opinion

DECISION AND ORDER

CURTIN, District Judge.

Plaintiff Excellus Health Plan, Inc. (“Excellus”) moves pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure to dismiss the counterclaims asserted against it by several defendants (Item 36). Oral argument of the motion was heard by the court on August 11, 2003. For the following reasons, plaintiffs motion to dismiss the counterclaims is granted in part and denied in part.

BACKGROUND

Excellus operates two principal lines of business in Western New York: a health maintenance organization (“HMO”) known as “Univera Healthcare,” and six medical centers doing business as the “Lifetime Health Centers.” Excellus commenced this action on February 5, 2003 against several physicians, administrators, and medical practice groups formerly affiliated with the Promedicus Health Group, LLP (“Promedicus”), shortly after Promedicus filed a Chapter 7 bankruptcy petition in the United States Bankruptcy Court for the Western District of New York. Excel-lus alleges that the defendants conspired to orchestrate a mass resignation from Promedicus in late 2002 in order to divert patients from the Lifetime Health Centers to the defendants’ new medical offices, and to divert enrollment from Univera Healthcare to other health insurance plans, resulting in group boycott, concerted refusal to deal, and price-fixing in violation of Section 1 of the Sherman Act (15 U.S.C. § 1) (Count I), tortious interference with current and prospective business relationships (Count II), unfair and deceptive trade practices (Count III), and unfair competition (Count IV) (see Item 1). The complaint seeks injunctive relief and compensatory and punitive damages, as well as treble damages under the Sherman Act (id). 1

On March 14, 2003, defendants Kathleen Mylotte, M.D., Allentown Pediatric and Adolescent Medicine, LLP, Amherst Medical Associates, LLP, Amhersi/Southgate ENT, LLP, Evergreen Women’s Health Group, LLP, Euville, LLP, Forestsream Pediatrics, LLP, Geriatric Associates, LLP, and Sheridan Drive Medical Group, LLP (collectively, “the Mylotte defendants”) filed an answer containing counterclaims for tortious interference with business opportunities, tortious interference with contract, defamation, unfair competition, and deceptive trade practices (Item 21). Dr. Mylotte was the Chief Executive Officer of Promedicus and is designated as the “registered agent” of defendant Geriatric Associates, LLP (id at ¶ 9). The remaining Mylotte defendants are medical practice groups formed in the fall of 2002 as limited liability partnerships (“LLPs”), consisting of former Promedicus physicians, including some who practiced at the Lifetime Health Centers.

Defendants Daniel T. Tran, Michael J. Edbauer, D.O., Health Care Solutions WNY, LLC (“HCS”), and ETV, LLC (collectively, “the Tran defendants”) also filed their answer on March 14, 2003, asserting counterclaims for tortious interference, unfair competition, deceptive trade practices, defamation, and unjust enrichment (Item *171 23). Mr. Tran and Dr. Edbauer served as President and Medical Director of Pro-medicus, respectively, and are officers of defendants ETV and Health Care Solutions (“HCS”). ETV is described in the answer as a limited liability company (“LLC”) functioning as the “sole owner” of HCS (Item 23, ¶¶73, 157). HCS is described as an independent limited liability company engaged in the business of managing physician practices and acting as billing agent for several of the medical practice LLPs sued as defendants in this case (see Item 46, pp. 2-3).

Defendant Lancaster/Southgate Medical Group, LLP (“Lancaster/Southgate”), also filed its answer on March 14, 2003, asserting counterclaims for tortious interference, unfair and deceptive trade practices, defamation, unjust enrichment, and violations of several New York State Department of Health regulations 2 (Item 24). Defendant Southwestern Medical Associates, LLP (“Southwestern”), filed its answer on March 31, 2003, asserting counterclaims for tortious interference, unfair and deceptive trade practices, and defamation (Item 32).

Defendant East Aurora Family Practice, LLP, filed its answer on March 18, 2003 (Item 25), and Springville Pediatrics and Adult Care, LLP, filed its answer on March 31, 2003 (Item 31). Neither of these defendants has asserted counterclaims.

On April 21, 2003, plaintiff filed its motion to dismiss the counterclaims (Item 36). The Tran defendants (Item 46), the Mylotte defendants (Item 49), and Lancaster/Southgate (Item 50) have filed memo-randa of law in opposition to the motion, 3 and plaintiff has filed a reply (Item 54). For the reasons set forth below, plaintiffs motion to dismiss the Mylotte defendants’ tortious interference with contract counterclaims is granted, with leave to replead. Plaintiffs motion to dismiss is denied in all other respects.

DISCUSSION

I. Rule 12(b)(6)

A motion to dismiss counterclaims is governed by the well-known standard for determining a motion under Rule 12(b)(6) to dismiss for failure to state a claim upon which relief can be granted. See Wells Fargo Bank Northwest, N.A. v. Taca International Airlines, S.A., 247 F.Supp.2d 352, 363 (S.D.N.Y.2002). Under that standard, the court must liberally construe the counterclaims, accepting as true the facts alleged, and may dismiss the claims only if “it appears beyond doubt that the plaintiff can prove no set of facts in support of his claim which would entitle him to relief.” Conley v. Gibson, 355 U.S. 41, 45-46, 78 S.Ct. 99, 2 L.Ed.2d 80 (1957), quoted in Lerman v. Bd. of Elections of New York, 232 F.3d 135, 140 (2d Cir.2000), cert. denied, 533 U.S. 915, 121 S.Ct. 2520, 150 L.Ed.2d 692 (2001).

In reviewing the motion to dismiss, all reasonable inferences must be drawn in the counterclaimant’s favor. Bolt Electric, Inc. v. The City of New York, 53 F.3d 465, 469 (2d Cir.1995). However, a court is not required to accept as true “conclusions of law or unwarranted deductions of fact.” First Nationwide Bank v. Gelt Funding Corp., 27 F.3d 763, 771 (2d Cir.1994), cert. denied, 513 U.S. 1079, 115 S.Ct. 728, 130 L.Ed.2d 632 (1995). In order to survive a motion to dismiss under Rule 12(b)(6), the *172 counterclaim “must allege facts that, if true, would create a judicially cognizable cause of action.” South Road Associates v. International Business Machines Corp., 216 F.3d 251, 253 (2d Cir.2000). A motion to dismiss merely addresses the legal sufficiency of a claim, not the weight of the evidence. See McCall v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daytree at Cortland Square, Inc. v. Walsh
332 F. Supp. 3d 610 (E.D. New York, 2018)
Nirvana, Inc. v. Nestle Waters North America Inc.
123 F. Supp. 3d 357 (N.D. New York, 2015)
WI3, Inc. v. Actiontec Electronics, Inc.
71 F. Supp. 3d 358 (W.D. New York, 2014)
Ground Zero Museum Workshop v. Wilson
813 F. Supp. 2d 678 (D. Maryland, 2011)
In Re Packaged Ice Antitrust Litigation
779 F. Supp. 2d 642 (E.D. Michigan, 2011)
Dupler v. Costco Wholesale Corp.
249 F.R.D. 29 (E.D. New York, 2008)
In Re Graphics Processing Units Antitrust Litigation
527 F. Supp. 2d 1011 (N.D. California, 2007)
Simons v. New York
472 F. Supp. 2d 253 (N.D. New York, 2007)
Burns v. Cook
458 F. Supp. 2d 29 (N.D. New York, 2006)
Pisani v. Staten Island University Hospital
440 F. Supp. 2d 168 (E.D. New York, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
287 F. Supp. 2d 167, 2003 U.S. Dist. LEXIS 18480, 2003 WL 22382948, Counsel Stack Legal Research, https://law.counselstack.com/opinion/excellus-health-plan-inc-v-tran-nywd-2003.